Right Dorsal Colitis

Right dorsal colitis in horses represents a specific and serious inflammatory condition affecting the right dorsal colon, a distinct segment of the large intestine located on the right side of the abdomen. This condition typically develops as a consequence of non-steroidal anti-inflammatory drug toxicity, with phenylbutazone being the most commonly implicated medication. The right dorsal colon appears particularly susceptible to NSAID-induced damage due to a combination of anatomical features, blood supply patterns, and the mechanisms by which these medications exert their effects. When the protective mucosal lining of this intestinal segment is compromised, severe ulceration, inflammation, and protein loss can result.

Right dorsal colitis can affect horses of any age, breed, or use, although the condition is most strongly associated with horses receiving chronic or high-dose non-steroidal anti-inflammatory drug therapy. Performance horses, particularly those in disciplines requiring intensive training and competition, may receive NSAIDs frequently for management of musculoskeletal discomfort, placing them at elevated risk. Horses with concurrent illnesses that reduce blood flow to the intestines, cause dehydration, or impair normal intestinal function face increased susceptibility to NSAID toxicity even at standard doses. The condition has become increasingly recognized as awareness of NSAID-related gastrointestinal effects has grown.

The impact of right dorsal colitis on equine health can be substantial and prolonged. Ulceration of the colonic mucosa leads to significant protein loss through the damaged intestinal wall, resulting in hypoproteinemia that manifests as edema of the legs, ventral abdomen, and other dependent tissues. Affected horses often experience recurrent or chronic colic, weight loss despite adequate nutrition, and poor body condition. The inflammation and ulceration impair normal digestive function, contributing to malabsorption of nutrients. If not recognized and appropriately managed, right dorsal colitis can become a chronic debilitating condition that significantly affects quality of life and athletic performance.

Early detection and appropriate management can lead to substantial improvement or complete resolution of right dorsal colitis in many horses. Recognition of the association with NSAID use allows identification of at-risk horses and modification of pain management strategies before severe damage occurs. Withdrawal of NSAIDs combined with dietary modifications and supportive care allows healing of ulcerated mucosa in many cases. However, some horses develop severe or chronic disease requiring extended treatment and may not return to previous function. Prevention through judicious use of NSAIDs and awareness of risk factors remains the most effective approach to this condition.

The primary cause of right dorsal colitis is toxicity from non-steroidal anti-inflammatory drugs, with phenylbutazone representing the most commonly implicated medication in equine cases. NSAIDs exert their therapeutic anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes that produce prostaglandins. However, certain prostaglandins also play protective roles in the gastrointestinal tract, maintaining mucosal blood flow, stimulating protective mucus production, and supporting epithelial cell turnover. When NSAID therapy suppresses these protective prostaglandins, the intestinal mucosa becomes vulnerable to injury from digestive acids, enzymes, and normal intestinal contents. The right dorsal colon appears particularly susceptible to this injury, likely due to its anatomical position, blood supply characteristics, and local factors affecting prostaglandin-dependent protection.

Other NSAIDs commonly used in horses can also cause right dorsal colitis, although phenylbutazone remains the most frequently implicated drug. Flunixin meglumine, widely used for colic pain and anti-endotoxin effects, carries similar gastrointestinal risk. Ketoprofen, firocoxib, and other available equine NSAIDs all share potential for intestinal toxicity, although newer COX-2 selective agents may carry somewhat lower risk. Combinations of NSAIDs, or concurrent use of NSAIDs with corticosteroids, dramatically increase gastrointestinal toxicity risk. The duration and dose of therapy both influence likelihood and severity of right dorsal colitis development, with chronic administration carrying higher risk than occasional use.

Environmental and management factors influence susceptibility to NSAID-induced right dorsal colitis by affecting intestinal blood flow and overall gastrointestinal health. Dehydration reduces blood volume and intestinal perfusion, making the mucosa more susceptible to NSAID effects. Horses undergoing strenuous exercise experience redistribution of blood flow away from the gastrointestinal tract, potentially increasing vulnerability during periods of NSAID use. Stress from transport, competition, or changes in management may compromise intestinal function. Dietary factors including low-forage diets, irregular feeding schedules, and limited access to water contribute to overall intestinal stress that may potentiate NSAID toxicity.

Risk factors for right dorsal colitis include any situation that increases NSAID exposure or decreases intestinal resilience to drug effects. Chronic musculoskeletal conditions requiring ongoing pain management represent the most common predisposing situation. Horses receiving NSAIDs at doses exceeding label recommendations face elevated risk, as do those maintained on therapeutic doses for extended periods. Concurrent illness, particularly conditions affecting hydration or cardiovascular function, increases susceptibility. Young horses may be more sensitive to NSAID effects than adults. Horses with pre-existing gastrointestinal conditions may have compromised mucosal protection. The combination of multiple risk factors dramatically increases the likelihood of developing clinically significant right dorsal colitis.

The pathophysiology of right dorsal colitis involves progressive mucosal injury from prostaglandin suppression combined with exposure to intestinal contents. When protective prostaglandin production is inhibited by NSAIDs, mucosal blood flow decreases, mucus production declines, and epithelial cell turnover slows. The intestinal lining becomes vulnerable to injury from bile acids, digestive enzymes, and mechanical trauma from fibrous ingesta. Ulceration develops and may extend through the full thickness of the mucosa. The damaged intestinal wall becomes permeable to proteins, which leak from blood vessels into the intestinal lumen and are lost in feces. Inflammation spreads through the colonic wall, causing pain, altered motility, and impaired absorption. In severe cases, perforation may occur, leading to fatal peritonitis.

Early warning signs of right dorsal colitis may develop gradually as intestinal damage accumulates from ongoing NSAID exposure. Subtle decreases in appetite or changes in eating behavior may precede more obvious symptoms. Mild, intermittent colic signs that seem disproportionate to findings on examination may indicate developing colitis. Slight changes in manure consistency, including softer stools or occasional diarrhea, can occur early. Some horses show decreased performance or reluctance to work that seems unrelated to their primary musculoskeletal condition. Weight loss may begin before other symptoms become apparent. Owners familiar with their horses may notice personality changes or decreased enthusiasm for normal activities.

Common symptoms of established right dorsal colitis include signs of chronic or recurrent abdominal discomfort. Affected horses often display mild to moderate colic episodes that may occur repeatedly over days to weeks. The colic pain may be intermittent and may seem to respond temporarily to additional NSAID administration, masking the underlying cause. Weight loss develops despite adequate caloric intake as protein loss and malabsorption take their toll. Decreased appetite is common, with some horses becoming finicky eaters or showing preferences for certain feeds while refusing others. Lethargy and decreased performance reflect both discomfort and metabolic consequences of the disease.

Behavioral changes associated with right dorsal colitis reflect chronic discomfort and systemic illness. Depression develops as horses feel persistently unwell. Affected animals may become girthy, resenting pressure around the abdomen during saddling or grooming. Some horses develop unusual eating patterns, taking small bites, chewing slowly, or stopping to stand quietly during meals. Preference for certain positions, particularly standing with the back arched or lying down more frequently than normal, may indicate abdominal discomfort. Social behavior may change, with affected horses becoming more withdrawn or occasionally irritable. The chronic nature of the condition leads to gradual deterioration rather than sudden dramatic change.

Physical signs on examination provide important diagnostic clues. Ventral edema represents one of the hallmark findings of right dorsal colitis, resulting from protein loss and decreased blood protein levels. Swelling typically appears first along the ventral midline, extending to include the legs, sheath or udder, and potentially the chest and face in severe cases. Body condition typically decreases despite adequate nutrition, with loss of muscle mass over the topline and ribcage. Coat quality may deteriorate. Heart rate may be mildly elevated during colic episodes but is often normal between episodes. Gut sounds may be decreased or altered in character. Rectal examination may reveal thickened intestinal walls in the region of the right dorsal colon, although this finding requires experience to interpret.

Symptom progression in right dorsal colitis follows a pattern of gradual deterioration if the underlying cause is not addressed. Early mild symptoms worsen over time as intestinal damage accumulates. Weight loss becomes more severe, and ventral edema more pronounced. Colic episodes may increase in frequency and intensity. Diarrhea may develop as colonic function becomes increasingly compromised. Anemia may occur from chronic blood loss through ulcerated mucosa. Without recognition and treatment, some horses develop life-threatening hypoproteinemia with severe generalized edema. Perforation of severely ulcerated intestine, though uncommon, leads to fatal peritonitis.

Emergency symptoms requiring immediate veterinary care include severe abdominal pain unresponsive to treatment, signs of cardiovascular compromise, profuse diarrhea, marked generalized edema suggesting severe protein loss, and any signs suggesting possible intestinal perforation such as rapid deterioration, fever, and signs of shock. Horses receiving NSAIDs that develop any concerning gastrointestinal signs should be evaluated promptly, even if symptoms initially seem mild. The insidious progression of right dorsal colitis means that significant damage may be present before dramatic symptoms develop, making early intervention crucial for optimal outcomes.

Physical examination of horses with suspected right dorsal colitis focuses on detecting evidence of protein loss, dehydration, and intestinal dysfunction. Careful assessment of body condition reveals weight loss that may have developed gradually over weeks to months. Inspection for ventral edema helps identify the protein-losing state characteristic of this condition. Vital signs assessment may reveal mild heart rate elevation during discomfort but often falls within normal ranges between colic episodes. Auscultation of the abdomen may reveal decreased or altered gut sounds reflecting abnormal motility. Rectal examination by an experienced practitioner may detect thickening of the right dorsal colon wall, providing direct evidence of the affected segment. Thorough history-taking focuses on identifying NSAID use, duration, and dosing patterns.

Diagnostic tests help confirm right dorsal colitis and assess severity of protein loss and systemic effects. Serum biochemistry reveals hypoproteinemia, with both albumin and globulin fractions typically decreased. Total protein levels below 5.5 grams per deciliter are common in significant cases, with severely affected horses dropping below 4 grams per deciliter. Complete blood count may show anemia from chronic blood loss and potentially changes in white blood cell counts reflecting inflammation. Peritoneal fluid analysis obtained through abdominocentesis may show elevated protein levels and mild increases in cell counts. Fecal examination may reveal occult blood from intestinal ulceration. Response to withdrawal of NSAIDs provides supportive evidence when clinical improvement follows medication cessation.

Advanced diagnostics provide more direct assessment of right dorsal colon pathology. Transabdominal ultrasonography allows visualization of the right dorsal colon wall thickness, with measurements exceeding nine millimeters strongly suggestive of right dorsal colitis. Experienced ultrasonographers can often identify the characteristic thickening pattern affecting this specific intestinal segment. Nuclear scintigraphy using radiolabeled white blood cells can identify areas of intestinal inflammation, providing supportive evidence when ultrasonographic findings are equivocal. Gastroscopy may be performed to evaluate for concurrent gastric ulceration, which commonly accompanies NSAID-induced intestinal disease. Rarely, biopsy obtained surgically or through colonoscopy provides definitive histopathological diagnosis.

Differential diagnosis for right dorsal colitis includes other causes of protein-losing enteropathy, chronic colic, and weight loss in horses. Inflammatory bowel disease causes similar protein loss and weight loss without the typical NSAID association. Intestinal lymphoma and other neoplastic conditions may produce comparable clinical presentations. Parasitic disease, particularly cyathostominosis, causes protein-losing enteropathy with diarrhea. Chronic salmonellosis or other infectious enterocolitis can produce prolonged protein loss. Sand enteropathy in regions with sandy soil may cause chronic colic and poor condition. Granulomatous enteritis, though uncommon, affects intestinal function and protein homeostasis. The combination of NSAID exposure history, characteristic ultrasonographic findings, and response to appropriate treatment typically distinguishes right dorsal colitis from these alternatives.

Emergency and immediate treatment of right dorsal colitis begins with cessation of all NSAID therapy, which is essential for allowing intestinal healing to begin. If the horse is receiving NSAIDs for an underlying painful condition, alternative pain management strategies must be implemented. Opioid analgesics including tramadol or butorphanol provide pain relief without intestinal toxicity. Intravenous fluid therapy addresses dehydration and supports cardiovascular function in horses with severe protein loss. Plasma transfusion may be necessary for horses with critically low protein levels to restore oncotic pressure and reduce edema. Colloid solutions can temporarily support blood volume while waiting for intestinal healing to restore normal protein homeostasis.

Medical management of right dorsal colitis focuses on protecting the damaged intestinal mucosa while it heals and supporting the horse nutritionally. Sucralfate, a mucosal protectant, binds to ulcerated surfaces and promotes healing. Psyllium mucilloid fiber supplements coat the intestinal wall and may provide physical protection to damaged areas. Misoprostol, a synthetic prostaglandin, replaces the protective prostaglandins suppressed by NSAID therapy and promotes mucosal healing. Omeprazole or other proton pump inhibitors help manage concurrent gastric ulceration commonly present in affected horses. Corn oil or other vegetable oils added to the diet provide calories while their fatty acid content may support intestinal healing.

Dietary modifications represent a cornerstone of right dorsal colitis treatment and recovery. Affected horses should receive high-quality, easily digestible feedstuffs that minimize intestinal workload. Good-quality grass hay forms the dietary foundation, as the fiber supports normal colonic function while being less irritating than coarser forage. Alfalfa hay is typically avoided initially due to concerns about protein content and potential irritation, although it may be reintroduced during recovery. Complete feeds designed for easy digestion may replace or supplement hay. Grain and concentrate feeds are minimized or eliminated, as hindgut fermentation of starches may exacerbate colonic inflammation. Frequent small meals reduce intestinal distension and workload. Access to water must be constant to maintain hydration.

Supportive care addresses the systemic effects of right dorsal colitis while healing progresses. Horses with significant edema may benefit from bandaging of the lower limbs to reduce fluid accumulation. Hand-walking helps mobilize edema fluid and supports intestinal motility. Monitoring of body weight, protein levels, and overall condition guides treatment adjustments. Stress reduction through consistent management routines, appropriate companionship, and comfortable housing supports recovery. Some horses require extended stall rest, while others can be maintained with limited turnout depending on severity and individual response to treatment.

Recovery management involves gradual reintroduction of normal diet and activity as intestinal healing progresses. Dietary changes are made slowly over weeks, monitoring for return of symptoms with each modification. Hay quality and quantity are gradually normalized. If grain is reintroduced, it occurs very slowly in small amounts. Exercise levels progress gradually as the horse's condition improves and comfort allows. Serial monitoring of blood protein levels confirms healing and guides pace of recovery progression. The process typically requires weeks to months, with severely affected horses needing the longest recovery periods.

Treatment decisions consider the severity of intestinal damage, systemic effects of protein loss, underlying conditions requiring pain management, and economic factors. Mildly affected horses may recover with NSAID withdrawal and dietary management alone. Severely affected horses may require hospitalization for intensive support including plasma transfusion. The need for ongoing pain management for underlying conditions must be balanced against intestinal health, often requiring creative use of alternative analgesics. Chronic cases that fail to respond adequately to treatment may face ongoing management challenges or, in severe cases, may not recover sufficient function for athletic use or comfortable retirement.

Recovery timeline for right dorsal colitis varies considerably based on severity of intestinal damage and promptness of intervention. Mildly affected horses identified early may show improvement within one to two weeks of NSAID withdrawal and begin normalization of protein levels within a month. Moderately affected horses typically require six to twelve weeks for substantial recovery, with ongoing improvement continuing for several months. Severely affected horses with profound protein loss and extensive ulceration may need three to six months or longer for clinical recovery, with some experiencing permanent intestinal changes. Complete histological healing of ulcerated mucosa may lag behind clinical improvement by weeks to months.

Post-treatment care and monitoring focus on confirming healing and preventing recurrence. Serial measurement of blood protein levels provides objective assessment of intestinal recovery, with gradual normalization expected over weeks. Body weight monitoring tracks nutritional recovery, with steady weight gain indicating improved intestinal function. Repeat ultrasonographic examination may be performed to assess resolution of right dorsal colon wall thickening. Close observation for return of colic signs or edema during dietary transition helps identify horses requiring continued modified management. Communication with the treating veterinarian allows adjustment of treatment plans based on individual response.

Prognosis for right dorsal colitis depends primarily on severity at time of diagnosis and response to treatment. Horses with mild disease identified early carry excellent prognosis for complete recovery and return to normal function. Those with moderate disease generally recover well but may require permanent dietary modifications or restriction from NSAID use. Severely affected horses face more guarded prognosis, with some developing chronic colonic dysfunction that impairs nutrient absorption and predisposes to recurrent colic. Horses that develop intestinal perforation face a grave prognosis, although this complication is uncommon with appropriate management. The need for ongoing pain management for underlying musculoskeletal conditions may complicate long-term prognosis if NSAID alternatives are inadequate.

Long-term outlook for horses recovering from right dorsal colitis requires ongoing attention to intestinal health and pain management strategies. Many horses return to full athletic function after appropriate treatment and recovery. Permanent changes in management may include avoidance or severe limitation of NSAID use, dietary modifications emphasizing high-quality forage over concentrates, and vigilance for early signs of gastrointestinal disturbance. Horses with chronic changes to colonic function may require lifelong dietary management and may experience episodes of colic requiring management. Quality of life remains good for most horses with appropriate ongoing care, although some may be limited in their athletic pursuits by either residual intestinal disease or difficulty managing underlying painful conditions without NSAIDs.

Management practices focused on judicious NSAID use represent the most effective prevention for right dorsal colitis. NSAIDs should be used at the lowest effective dose for the shortest duration necessary to achieve therapeutic goals. Label recommendations for dosing and duration should be followed carefully, with veterinary guidance for any deviation from standard protocols. Combining NSAIDs with other NSAIDs or with corticosteroids should be avoided due to dramatically increased gastrointestinal toxicity. When chronic pain management is necessary, alternative therapies including joint injections, systemic joint-supporting supplements, physical therapy, and regenerative medicine should be explored to reduce NSAID requirements. Regular veterinary evaluation helps optimize pain management while minimizing gastrointestinal risk.

Nutritional prevention strategies support intestinal health and may provide some protection during necessary NSAID use. High-forage diets appropriate for hindgut fermenters support normal colonic function and may enhance mucosal resistance to injury. Adequate hydration maintains intestinal blood flow and supports mucosal health. Avoiding prolonged periods without access to forage reduces gastric acid exposure and supports normal intestinal motility. When horses require NSAID therapy, concurrent administration of gastric protectants and mucosal-coating supplements may provide some protection. Maintaining appropriate body condition without obesity supports overall health and may facilitate reduced NSAID requirements.

Exercise and conditioning programs that minimize injury reduce the need for NSAID therapy and thereby decrease right dorsal colitis risk. Appropriate warm-up and conditioning prevent musculoskeletal injuries requiring pain management. Correct training progression avoids overloading immature skeletal structures. Good footing in turnout and work areas prevents traumatic injuries. Attention to hoof care and shoeing reduces the development of chronic lameness requiring ongoing medication. Early and appropriate treatment of acute injuries may prevent development of chronic conditions requiring long-term NSAID use.

Environmental factors affecting stress levels and hydration influence susceptibility to NSAID toxicity. Ensuring constant access to fresh water supports hydration and intestinal health. Reducing stress through consistent routines, appropriate turnout, and compatible social groups supports overall wellness. Avoiding excessive transport during periods of NSAID use reduces combined stressors. Temperature management during extreme weather prevents physiological stress that might compound medication effects. Attention to overall management supports intestinal resilience during periods when NSAID use becomes necessary.

Regular veterinary involvement in preventive care helps identify developing musculoskeletal problems before they require intensive NSAID therapy and ensures appropriate medication use when needed. Annual or semi-annual wellness examinations allow early detection of lameness issues amenable to targeted treatment. Dental care supports proper feed utilization. Vaccination and deworming protocols maintain overall health. For horses requiring chronic pain management, regular veterinary reassessment ensures optimal use of available therapies while monitoring for early signs of gastrointestinal complications. Blood work monitoring during extended NSAID use can detect protein loss before clinical signs develop.

Daily management adjustments for horses at risk for or recovering from right dorsal colitis focus on supporting intestinal health while managing pain through alternatives to NSAIDs. Feeding schedules should provide small frequent meals rather than large infrequent feedings, reducing intestinal workload and supporting continuous fiber intake. High-quality grass hay should form the foundation of the diet, with amounts adjusted to maintain appropriate body condition. Water intake should be monitored and encouraged through provision of clean, palatable water sources. Daily observation includes assessment of appetite, manure consistency, and signs of abdominal discomfort. Recording observations helps identify trends that might indicate developing problems or confirm improvement.

Housing and turnout considerations balance the benefits of movement against any limitations imposed by underlying musculoskeletal conditions. Maximum appropriate turnout supports intestinal motility and general wellness. Pasture access provides continuous forage intake that supports colonic health, though care should be taken to avoid lush pasture that might cause hindgut upset. Stall housing should provide clean, well-bedded environments when turnout is limited. Social contact with compatible companions reduces stress. Environmental temperature management prevents physiological stress that might compromise intestinal function. Clean water sources in both stall and turnout environments ensure constant hydration.

Exercise modifications depend on both the intestinal condition and any underlying musculoskeletal issues that may have prompted NSAID use. During active disease, exercise may need to be limited to gentle hand-walking that promotes intestinal motility without causing discomfort. As recovery progresses, activity can be gradually increased based on the horse's comfort and condition. For horses with chronic musculoskeletal problems, exercise programs should be carefully designed to maintain fitness while minimizing strain. Physical therapy modalities including therapeutic ultrasound, laser therapy, and targeted exercises may help manage underlying painful conditions. Cold and heat therapy provide temporary pain relief without intestinal risk.

Monitoring and ongoing care requirements include vigilance for early signs of gastrointestinal disturbance and regular assessment of overall health. Body weight should be monitored at least monthly to detect early weight loss that might indicate recurrence. Manure consistency and production provide daily information about intestinal function. Any return of edema, decreased appetite, or signs of colic warrants prompt veterinary evaluation. Periodic blood work may be recommended to monitor protein levels, particularly during transitions in management. Regular veterinary examinations allow adjustment of pain management protocols and early detection of complications.

Quality of life and use considerations guide long-term planning for horses affected by right dorsal colitis. Many horses return to full athletic function after recovery, particularly if alternative pain management strategies adequately address underlying conditions. Some horses may be limited by inability to use NSAIDs when circumstances would normally call for their use, such as after minor injuries or during recovery from other conditions. Horses with residual colonic dysfunction may require permanent dietary modifications that limit their management flexibility. Quality of life assessment considers comfort, ability to maintain body condition, and enjoyment of daily activities. For horses whose underlying musculoskeletal conditions cannot be adequately managed without NSAIDs, modifications to athletic goals or retirement to pasture may provide the best quality of life while protecting intestinal health.

Right dorsal colitis does not demonstrate breed-specific predilection, as the condition results from NSAID toxicity rather than inherited factors. Any horse of any breed may develop right dorsal colitis if exposed to sufficient NSAID therapy. However, certain breeds may face elevated risk based on typical use patterns and associated musculoskeletal demands. Thoroughbreds and other breeds used for racing commonly receive NSAIDs for management of training-related injuries and post-race recovery. Warmbloods and sport horses in demanding disciplines including dressage, show jumping, and eventing may receive chronic NSAID therapy for joint and soft tissue management. Western performance horses, particularly those in reining, cutting, and barrel racing, experience significant musculoskeletal stress that may prompt NSAID use.

Use and discipline considerations affect right dorsal colitis risk more significantly than breed heritage. Horses in high-intensity training and competition programs face greater musculoskeletal demands that may prompt NSAID use. Show horses receiving medications to maintain comfort during competition seasons experience cumulative NSAID exposure. Horses with chronic lameness issues from conformational faults, previous injuries, or degenerative conditions may receive long-term NSAID therapy regardless of breed. Conversely, pleasure horses and retirees typically receive less NSAID exposure and face lower risk. The key risk factor is the pattern and duration of NSAID use rather than breed-specific susceptibility.

Genetic testing offers no assessment for right dorsal colitis susceptibility, as the condition results from medication effects rather than inherited traits. No genetic markers predicting NSAID sensitivity in horses have been identified for clinical use. Individual variation in NSAID metabolism and gastrointestinal resilience likely exists but has not been characterized genetically. Breeding decisions do not incorporate right dorsal colitis considerations. However, selection for sound conformation that reduces the likelihood of developing chronic lameness may indirectly reduce lifetime NSAID exposure and associated gastrointestinal risk. As pharmacogenomics advances, genetic factors affecting NSAID metabolism may eventually be identified, allowing personalized risk assessment and dosing strategies.

Commonly co-occurring conditions with right dorsal colitis reflect both the underlying situations that prompt NSAID use and the effects of these medications on other body systems. Gastric ulceration commonly accompanies right dorsal colitis, as NSAIDs affect the stomach mucosa through similar prostaglandin-dependent mechanisms. Horses with right dorsal colitis should be assumed to have concurrent gastric ulceration requiring treatment. The musculoskeletal conditions that prompted NSAID use continue to require management, often necessitating alternative pain control strategies. Stress-related behaviors and conditions may develop from chronic discomfort. Horses with severe protein loss may develop secondary complications including impaired wound healing, susceptibility to infection, and muscle wasting.

Conditions with similar symptoms requiring differentiation from right dorsal colitis include other causes of protein-losing enteropathy and chronic colic. Inflammatory bowel disease produces similar protein loss, weight loss, and intermittent colic without the typical NSAID association. Lymphosarcoma affecting the intestine can cause protein loss and similar clinical presentation. Parasitic disease, particularly larval cyathostominosis, causes protein-losing enteropathy with diarrhea. Granulomatous enteritis produces chronic weight loss and intestinal dysfunction. Chronic sand accumulation causes recurrent colic and poor condition in regions with sandy soil. Intestinal adhesions from previous surgery or inflammation cause chronic intermittent colic. The NSAID exposure history and characteristic ultrasonographic findings help distinguish right dorsal colitis from these alternatives.

Potential complications of right dorsal colitis include serious consequences of severe or prolonged disease. Intestinal perforation, though uncommon, leads to fatal peritonitis if it occurs. Severe hypoproteinemia causes generalized edema affecting limbs, ventral body, and potentially internal organs. Thrombophlebitis may occur from prolonged intravenous catheterization during treatment. Chronic colonic dysfunction may persist after acute disease resolves, causing ongoing digestive difficulties and susceptibility to colic. Nutritional deficiencies may develop from impaired absorption. Concurrent gastric ulceration may become severe if not addressed. Laminitis represents a potential complication of systemic illness, particularly in horses requiring prolonged stall rest during recovery.